{"1": ["Breast neoplasm", "Hereditary breast cancer", "Male breast cancer", "Male breast cancer genetics", "Male breast cancer treatment", "breast cancer", "Breast cancer", "Cancer-associated fibroblast", "Advanced breast cancer", "Metastatic breast cancer", "Breast cancer recurrence", "Postmenopausal breast cancer", "Premenopausal breast cancer", "male breast cancer", "Breast cancer surgery", "Lobular breast cancer", "metaplastic breast cancer", "tumorigenesis", "breast cancer in young", "Breast cancer in young women", "Early onset breast cancer", "Management of breast cancer", "Radiation for breast cancer", "Surgery for breast cancer", "Breast cancer subtypes", "Metastasis", "Breast cancer detection", "Breast cancer precursor lesions", "Ductal carcinoma in\u00a0situ", "Advanced-stage cancer", "breast cancer stem cells", "triple negative breast cancer", "cancer associated fibroblast", "Breast Cancer", "triple-negative breast cancer", "Tumor aggressiveness", "HER2+ breast cancer", "Triple negative breast cancer", "Breast Neoplasms", "Breast neoplasms", "Inflammatory breast cancer"], "7": ["biomarkers", "Biomarker", "clinical sequencing", "multi-omics", "Therapeutic approach", "Drug resistance", "Tumour oxygenation status", "risk factors", "Genomics", "Risk factors", "targeted therapy", "drug screening", "personalized treatment", "tumor research models", "Crosstalk", "Therapeutic targets", "Deep learning", "machine learning", "microbiome", "biomarker", "reverse-phase protein array", "targeted therapy.", "therapeutic perspectives", "Multi-gene panel testing", "Cancer neuroscience", "Landmark clinical trials", "MiR-192", "MiR-192 family", "MiR-194", "MiR-215", "Genetic variants", "Targeted therapy", "Liquid biopsy", "liquid biopsy", "radiomics", "drug resistance", "hydrogel", "vaccine kinetics", "Silico analysis", "Cancer diagnostics", "Prognostic biomarker", "Machine Learning", "Radiomics", "Histopathology"], "9": ["checkpoint inhibitors", "immunotherapy", "Chemo-sensitizers", "Co-delivery of drug and genes", "Novel anti-neoplastic agents", "Cancer immunotherapy", "Oncolytic virus", "Datopotamab deruxtecan", "Sacituzumab govitecan", "Hyperthermia", "Thermo-radiotherapy", "Chronotherapy", "Oligometastatic", "Oligoprogressive", "Stereotactic body radiotherapy", "treatment modalities", "Antibody\u2013drug conjugate", "recurrence", "endocrine treatment resistance", "Axillary management", "Chemotherapy for breast cancer", "Contralateral prophylactic mastectomy", "T cell immunotherapy", "Oncogenic viruses", "Chemotherapy", "Endocrine therapy", "Cryoablation", "Antihistamine", "chemotherapy", "immunologic therapy", "Mastectomy", "Neoadjuvant chemotherapy", "Neoadjuvant systemic therapy", "Short and long-term morbidity", "Physiotherapy", "mastectomy", "Tumor emboli", "bibliometric analysis", "immunotherapy resistance"], "8": ["CircRNA", "mutual exclusivity", "Elacestrant", "Estrone", "RNA", "HER2", "TKT", "VUS", "CRISPR", "GWAS", "lncRNA", "Menin", "NF-\u03baB", "circRNA", "DCIS", "Breast MRI", "CEM", "CAR-T", "MicroRNA", "EMT", "GAS5", "CiteSpace"], "3": ["Diagnosis", "Treatment", "surveillance", "Breast", "Cancer", "Inflammatory", "Survival", "diagnosis", "cancer", "resistance", "transcription", "ER", "Metabolism", "Therapy", "glucose", "navigation", "Resistance", "Incidence", "Mortality", "Proliferation", "review", "Progression", "Arm", "Illusion", "Positive", "Complaints", "Survivors", "mechanisms"], "2": ["co-occurrence", "precision treatment", "health maintenance", "side effects", "survivorship", "Immune resistance", "Combination therapy", "Oxygen delivery", "Estrogen", "Fatty acid", "Insulin resistance", "Obesity", "Imaging", "apoptosis", "genetic characteristics", "protein molecular characteristics", "organoids", "predictive", "subtype", "regulatory cell death", "Immune cells", "Gene expression", "Therapy response", "NGS", "gene expression", "Innervation", "Neuro-dependence", "Peripheral nerve damage", "amino acid", "immune escape", "lipid", "Viral infections", "combination therapy", "Cell proliferation", "supportive care program", "young women", "Cancer therapy", "Physical exercises", "Ultrasound", "Cancer diagnosis", "Delayed diagnosis", "Physical activity", "clinical trials", "metastasis.", "cancer stem cells", "imaging", "Pathogenesis", "Systematic review", "treatment.", "Histamine", "vascular normalization", "cancer vaccine", "Mirror feedback", "Pain", "Metastatic", "Apoptosis", "Surgical management", "Magnetic Resonance Imaging", "kinesiotherapy", "Molecular mechanism", "Therapeutic tolerance"], "4": ["Tumor microenvironment", "Tumor-associated macrophage", "Circadian gene regulation", "Circadian rhythms", "epidemiology", "autophagy", "Epidemiology", "Post-translational modifications", "SUMOylation", "extracellular matrix", "Epigenetic regulation", "Epigenetic therapy", "coregulators", "Chromatin regulators", "Cofactors", "Epigenetics", "Epigenomics", "Transcription factors", "tumor microenvironment", "Neural microenvironment", "exosomes", "extracellular vesicles", "Exosomes", "Extracellular vesicles", "metabolic reprogramming", "Angiogenesis", "tumor microenvironment (TME)", "nanoparticles", "Tumor Microenvironment"], "0": ["Capivasertib", "diagnosis of MBC", "cuproptosis", "ferroptosis", "necroptosis", "pyroptosis", "RNA-binding protein", "BI-2536", "PANoptosis", "HER2-low", "G6PD", "BRCA genes", "AR-V7 splice variant", "Cas13 screen", "DNA replication", "DNA repair", "Ethiopia", "GD2", "GD3", "naxitamab", "ctDNA", "DNA methylation", "MRPL13", "MiRNA testing", "VOSviewer"], "6": ["Tumour hypoxia", "Aromatase", "Aryl hydrocarbon receptor (AHR)", "Cancer-associated adipocytes (CAAs)", "Cyclin D1", "Estrogen receptor (ER)", "Human epidermal growth factor receptor 2 (HER2)", "Hyperinsulinemia", "Hypoxia", "Insulin-like growth factor (IGF)", "Leptin resistance", "Liver X receptor (LXR)", "Mammalian target of rapamycin (mTOR)", "Oxysterol 27-hydroxycholesterol (27HC)", "Progesterone receptor (PR)", "Sex hormone-binding globulin (SHBG)", "Adiponectin", "immunohistochemistry", "endocrine dependency", "estrogen receptor alpha", "androgen receptor", "Long noncoding RNA", "Multiple endocrine neoplasia type 1 (MEN1)", "Menopausal hormone therapy", "quality of life", "hyperoxic-hypoxic enigma", "hypoxia", "hypoxia paradox", "hypoxia-inducible factors", "progesterone receptor", "Toll-like receptors (TLRs)", "MiR-21 overexpression", "Quality of Life", "Immunohistochemistry", "Integrin \u03b21"], "5": ["Prognosis", "prognostic", "prognosis"]}